Use of a Point-of-Care Progesterone Assay to Predict Onset of Parturition in the Bitch

被引:4
|
作者
Nothling, Johan O. [1 ]
Joone, Carolynne J. [2 ]
Hegarty, Evan [3 ]
Schooley, Elizabeth K. [3 ]
De Cramer, Kurt G. M. [1 ]
机构
[1] Univ Pretoria, Fac Vet Sci, Dept Prod Anim Studies, Pretoria, South Africa
[2] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Div Trop Hlth & Med, Townsville, Qld, Australia
[3] IDEXX Labs Inc, Westbrook, ME USA
基金
新加坡国家研究基金会;
关键词
dog; whelp; chemiluminescent immunoassay; vaginoscopy; Catalyst; P4; in-house analyzer; IDEXX; PLASMA PROGESTERONE; SERUM PROGESTERONE; CANINE; BLOOD; TIME; TEMPERATURE; MATURATION; PREGNANCY; PRECISION; CORTISOL;
D O I
10.3389/fvets.2022.914659
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
An assay of circulating progesterone (P4) is commonly used to estimate progress through late gestation in the bitch. Point-of-care assays provide rapid results, a major advantage over laboratory-based assays. This study aims to compare P4 levels determined by the Catalyst (R) Progesterone point-of-care assay with those determined by chemiluminescent immunoassay (CLIA) and to identify the expected distribution of Catalyst P4 levels at time intervals 3 days prior to the onset of parturition in pregnant bitches. Twenty-eight pregnant bitches carrying two or more fetuses were admitted to a specialist veterinary reproduction hospital 53 days after the onset of cytological diestrus or, when that date was not known, 57 days after the last mating. Vaginal speculum examinations were performed every 6 h until the onset of cervical dilatation (TCD). Serum samples were collected twice daily (08h00 and 18h00) until TCD. For most samples, fresh serum was assayed for P4 immediately using the Catalyst assay (CatP4), then frozen until assayed by CLIA (IMMULITE 2000; ImmP4). However, for some samples, CatP4 was not analyzed prior to freezing. For these data points (n = 33), CatP4 for fresh serum was estimated from CatP4 assayed on frozen-thawed serum, based on a comparison between CatP4 on fresh vs. frozen-thawed sera. In comparison to ImmP4, CatP4 levels up to and including 7 nmol/L appear to have a constant bias of -1.69 nmol/L (limits of agreement -4.91 to 1.52), while levels >7 nmol/L appear to have a proportional bias of -17.9% (limits of agreement -68.6% to 32.7%). Bootstrapped percentiles of CatP4 results spanned 0.4-9 nmol/L within 12 h of TCD, 0.9-11 nmol/L 12-24 h from TCD, and 2.2-13.5 nmol/L 24-36 h from TCD. A CatP4 >9 nmol/L indicates a bitch that is unlikely to reach TCD within 12 h. Bitches with CatP4s below 3.5 nmol/L are likely to reach TCD within 36 h and bitches with a CatP4 below 2.2 nmol/L are likely to reach TCD within 24 h. In conclusion, the Catalyst Progesterone assay provides rapid assessment of circulating P4 in the bitch, with clinical application in the monitoring of late term pregnant bitches.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Use of serum progesterone and prostaglandin F2α metabolite levels to predict onset of parturition in the bitch
    Nothling, Johan Oliviette
    Joone, Carolynne Jane
    De Cramer, Kurt G. M.
    REPRODUCTION IN DOMESTIC ANIMALS, 2022, 57 (06) : 635 - 642
  • [2] Comparison of a Point-of-Care Analyzer With a Chemiluminescent Immunoassay for Serum Progesterone Measurement in Breeding Management of the Bitch
    Zuercher, Julia
    Boes, Katie M.
    Balogh, Orsolya
    Helms, Alyssa B.
    Cecere, Julie T.
    FRONTIERS IN VETERINARY SCIENCE, 2021, 8
  • [4] ADAPTATION OF A POINT-OF-CARE CANINE PROGESTERONE TEST FOR USE OF PARTURITION PREDICTION IN CAPTIVE ASIAN ELEPHANTS (ELEPHAS MAXIMUS): PROOF OF CONCEPT
    Molenaar, Fieke M.
    Rowcliffe, Marcus
    Lakey, Andrew
    JOURNAL OF ZOO AND WILDLIFE MEDICINE, 2022, 53 (04) : 791 - 796
  • [5] The precision of predicting the time of onset of parturition in the bitch using the level of progesterone in plasma during the preparturient period
    De Cramer, K. G. M.
    Nothling, J. O.
    THERIOGENOLOGY, 2018, 107 : 211 - 218
  • [6] The use of point-of-care ultrasound in new-onset dyspnea: an unexpected diagnosis
    Ozpak, Emine
    Defruyt, Loran
    Braeckeveldt, Laura
    Czapla, Jens
    Vandecasteele, Els
    ACTA CLINICA BELGICA, 2022, 77 (01) : 153 - 156
  • [7] Validation of a smartphone-based point-of-care hemoglobin assay for use in dogs
    Farrell, Kate S.
    Chapman, Phillip L.
    Sullivan, Lauren A.
    JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE, 2017, 27 (02) : 206 - 211
  • [8] Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It?
    Flores, Julio
    Cancino, Juan Carlos
    Chavez-Galan, Leslie
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [9] Evaluation of the point-of-care bioNexia® CRPplus assay
    Van Aelst, S.
    Mewis, A.
    Cardinaels, H.
    Hermans, R.
    Trossard, E.
    ACTA CLINICA BELGICA, 2015, 70 : S16 - S16
  • [10] Prehospital use of a modified HEART Pathway and point-of-care troponin to predict cardiovascular events
    Stopyra, Jason P.
    Snavely, Anna C.
    Smith, Lane M.
    Harris, R. David
    Nelson, Robert D.
    Winslow, James E.
    Alson, Roy L.
    Pomper, Gregory J.
    Riley, Robert F.
    Ashburn, Nicklaus P.
    Hendley, Nella W.
    Gaddy, Jeremiah
    Woodrum, Tyler
    Fornage, Louis
    Conner, David
    Alvarez, Manrique
    Pflum, Adam
    Koehler, Lauren E.
    Miller, Chadwick D.
    Mahler, Simon A.
    PLOS ONE, 2020, 15 (10):